120 related articles for article (PubMed ID: 11157723)
1. Adenoviral expression of a urokinase receptor-targeted protease inhibitor inhibits neointima formation in murine and human blood vessels.
Quax PH; Lamfers ML; Lardenoye JH; Grimbergen JM; de Vries MR; Slomp J; de Ruiter MC; Kockx MM; Verheijen JH; van Hinsbergh VW
Circulation; 2001 Jan; 103(4):562-9. PubMed ID: 11157723
[TBL] [Abstract][Full Text] [Related]
2. In vivo suppression of restenosis in balloon-injured rat carotid artery by adenovirus-mediated gene transfer of the cell surface-directed plasmin inhibitor ATF.BPTI.
Lamfers ML; Lardenoye JH; de Vries MR; Aalders MC; Engelse MA; Grimbergen JM; van Hinsbergh VW; Quax PH
Gene Ther; 2001 Apr; 8(7):534-41. PubMed ID: 11319620
[TBL] [Abstract][Full Text] [Related]
3. Gene transfer of the urokinase-type plasminogen activator receptor-targeted matrix metalloproteinase inhibitor TIMP-1.ATF suppresses neointima formation more efficiently than tissue inhibitor of metalloproteinase-1.
Lamfers ML; Grimbergen JM; Aalders MC; Havenga MJ; de Vries MR; Huisman LG; van Hinsbergh VW; Quax PH
Circ Res; 2002 Nov; 91(10):945-52. PubMed ID: 12433840
[TBL] [Abstract][Full Text] [Related]
4. Adenoviral gene transfer of a u-PA receptor-binding plasmin inhibitor and green fluorescent protein: inhibition of migration and visualization of expression.
Lamfers ML; Wijnberg MJ; Grimbergen JM; Huisman LG; Aalders MC; Cohen FN; Verheijen JH; van Hinsbergh VW; Quax PH
Thromb Haemost; 2000 Sep; 84(3):460-7. PubMed ID: 11019972
[TBL] [Abstract][Full Text] [Related]
5. A novel urokinase receptor-targeted inhibitor for plasmin and matrix metalloproteinases suppresses vein graft disease.
Eefting D; Seghers L; Grimbergen JM; de Vries MR; de Boer HC; Lardenoye JW; Jukema JW; van Bockel JH; Quax PH
Cardiovasc Res; 2010 Nov; 88(2):367-75. PubMed ID: 20562095
[TBL] [Abstract][Full Text] [Related]
6. In vivo suppression of vein graft disease by nonviral, electroporation-mediated, gene transfer of tissue inhibitor of metalloproteinase-1 linked to the amino terminal fragment of urokinase (TIMP-1.ATF), a cell-surface directed matrix metalloproteinase inhibitor.
Eefting D; de Vries MR; Grimbergen JM; Karper JC; van Bockel JH; Quax PH
J Vasc Surg; 2010 Feb; 51(2):429-37. PubMed ID: 20036101
[TBL] [Abstract][Full Text] [Related]
7. Adenoviral gene transfer of angiostatic ATF-BPTI inhibits tumour growth.
Lefesvre P; Attema J; van Bekkum D
BMC Cancer; 2002 Jul; 2():17. PubMed ID: 12147175
[TBL] [Abstract][Full Text] [Related]
8. Adenoviral delivery of a constitutively active retinoblastoma mutant inhibits neointima formation in a human explant model for vein graft disease.
Lamfers ML; Aalders MC; Grimbergen JM; de Vries MR; Kockx MM; van Hinsbergh VW; Quax PH
Vascul Pharmacol; 2002 Dec; 39(6):293-301. PubMed ID: 14567067
[TBL] [Abstract][Full Text] [Related]
9. [Mechanism of tumor cell-induced extracellular matrix degradation--inhibition of cell-surface proteolytic activity might have a therapeutic effect on tumor cell invasion and metastasis].
Kobayashi H
Nihon Sanka Fujinka Gakkai Zasshi; 1996 Aug; 48(8):623-32. PubMed ID: 8808830
[TBL] [Abstract][Full Text] [Related]
10. Adenoviral activin a expression prevents intimal hyperplasia in human and murine blood vessels by maintaining the contractile smooth muscle cell phenotype.
Engelse MA; Lardenoye JH; Neele JM; Grimbergen JM; De Vries MR; Lamfers ML; Pannekoek H; Quax PH; De Vries CJ
Circ Res; 2002 May; 90(10):1128-34. PubMed ID: 12039804
[TBL] [Abstract][Full Text] [Related]
11. Receptor-independent role of urokinase-type plasminogen activator in pericellular plasmin and matrix metalloproteinase proteolysis during vascular wound healing in mice.
Carmeliet P; Moons L; Dewerchin M; Rosenberg S; Herbert JM; Lupu F; Collen D
J Cell Biol; 1998 Jan; 140(1):233-45. PubMed ID: 9425170
[TBL] [Abstract][Full Text] [Related]
12. Amino-terminal fragment of urokinase inhibits tumor cell invasion in vitro and in vivo: respective contribution of the urokinase plasminogen activator receptor-dependent or -independent pathway.
Li H; Soria C; Griscelli F; Opolon P; Soria J; Yeh P; Legrand C; Vannier JP; Belin D; Perricaudet M; Lu H
Hum Gene Ther; 2005 Oct; 16(10):1157-67. PubMed ID: 16218777
[TBL] [Abstract][Full Text] [Related]
13. Adenovirus-mediated gene transfer of urokinase plasminogen inhibitor inhibits angiogenesis in experimental arthritis.
Apparailly F; Bouquet C; Millet V; Noel D; Jacquet C; Opolon P; Perricaudet M; Sany J; Yeh P; Jorgensen C
Gene Ther; 2002 Feb; 9(3):192-200. PubMed ID: 11859422
[TBL] [Abstract][Full Text] [Related]
14. Cartilage degradation and invasion by rheumatoid synovial fibroblasts is inhibited by gene transfer of a cell surface-targeted plasmin inhibitor.
van der Laan WH; Pap T; Ronday HK; Grimbergen JM; Huisman LG; TeKoppele JM; Breedveld FC; Gay RE; Gay S; Huizinga TW; Verheijen JH; Quax PH
Arthritis Rheum; 2000 Aug; 43(8):1710-8. PubMed ID: 10943860
[TBL] [Abstract][Full Text] [Related]
15. Enhancement of neointima formation with tissue-type plasminogen activator.
Hilfiker PR; Waugh JM; Li-Hawkins JJ; Kuo MD; Yuksel E; Geske RS; Cifra PN; Chawla M; Weinfeld AB; Thomas JW; Shenaq SM; Dake MD
J Vasc Surg; 2001 Apr; 33(4):821-8. PubMed ID: 11296338
[TBL] [Abstract][Full Text] [Related]
16. Plasmin-mediated fibroblast growth factor-2 mobilisation supports smooth muscle cell proliferation in human saphenous vein.
George SJ; Johnson JL; Smith MA; Jackson CL
J Vasc Res; 2001; 38(5):492-501. PubMed ID: 11561151
[TBL] [Abstract][Full Text] [Related]
17. Amino-terminal fragment of urokinase-type plasminogen activator inhibits its plasminogen activation.
Sun Z; Zhang PX; Wang P; Gurewich V; Shen HY; Liu JN
Thromb Res; 2002 Apr; 106(2):105-11. PubMed ID: 12182908
[TBL] [Abstract][Full Text] [Related]
18. Adenovirus-mediated transfer of the herpes simplex virus thymidine kinase gene inhibits vascular smooth muscle cell proliferation and neointima formation following balloon angioplasty of the rat carotid artery.
Chang MW; Ohno T; Gordon D; Lu MM; Nabel GJ; Nabel EG; Leiden JM
Mol Med; 1995 Jan; 1(2):172-81. PubMed ID: 8529096
[TBL] [Abstract][Full Text] [Related]
19. Transforming growth factor-beta is activated by plasmin and inhibits smooth muscle cell death in human saphenous vein.
George SJ; Johnson JL; Smith MA; Angelini GD; Jackson CL
J Vasc Res; 2005; 42(3):247-54. PubMed ID: 15870504
[TBL] [Abstract][Full Text] [Related]
20. Adenovirus-mediated expression of a truncated PDGFbeta receptor inhibits thrombosis and neointima formation in an avian arterial injury model.
Ding H; Wang R; Marcel R; Fisher DZ
Thromb Haemost; 2001 Sep; 86(3):914-22. PubMed ID: 11583327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
